| Product NDC: | 25021-801 |
| Proprietary Name: | zoledronic acid |
| Non Proprietary Name: | zoledronic acid |
| Active Ingredient(s): | .8 mg/mL & nbsp; zoledronic acid |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-801 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202472 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130302 |
| Package NDC: | 25021-801-66 |
| Package Description: | 1 VIAL in 1 CARTON (25021-801-66) > 5 mL in 1 VIAL |
| NDC Code | 25021-801-66 |
| Proprietary Name | zoledronic acid |
| Package Description | 1 VIAL in 1 CARTON (25021-801-66) > 5 mL in 1 VIAL |
| Product NDC | 25021-801 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zoledronic acid |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130302 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | ZOLEDRONIC ACID |
| Strength Number | .8 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |